Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphangioleiomyomatosis × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 5 Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Colorectal Neoplasms 5 Small Cell Lung Carcinoma 4 Rectal Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Fibrosis 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Sprains and Strains 1 Smoldering Multiple Myeloma 1 Sepsis 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Sirolimus 10 Everolimus 4 Imatinib Mesylate 2 temsirolimus 1 saracatinib 1 carbon-11 acetate 1 Valproic Acid 1 Urination 1 Sugars 1 Simvastatin 1 Resveratrol 1 Respiratory Function Tests 1 Phlebotomy 1 Octreotide 1 Loratadine 1 Letrozole 1 Immunoglobulin G 1 Hydroxychloroquine 1 Genetic Testing 1 Doxycycline 1 Disulfides 1 Cetuximab 1 Celecoxib 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed

10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡